The Adoption of Prescription Digital Therapeutics and Its Challenges Amongst Payers | Asembia Specialty Pharmacy Summit
Today at the annual Asembia Specialty Summit in Las Vegas, Sarah Marche, VP of Pharmacy at Highmark Health, spoke alongside other professionals from various stakeholders within the industry who are invested some way in digital therapeutics.
Prescription digital therapeutics are increasingly becoming an important part of how we manage diseases, said Sarah Marche, VP of Pharmacy at Highmark Health, in the interview above with Managed Healthcare Executive.
"I'd say more and more patients are turning to apps and their phones to supplement how they're treating certain disease states," she added.
Today at the annual Asembia Specialty Summit in Las Vegas, Marche spoke alongside other professionals from various stakeholders within the industry who are invested some way in digital therapeutics.
Marche dove into her discussion focusing on payer's perspectives on the coverage of precription digital therapeutics.
"There are some issues we see with (prescription digital therapeutics)," Marche said. "I run the pharmacy benefit for Highmark and we're used to very robust and structured clinical data and studies. The studies that we see around digital therapeutics are not similar to what we're used to seeing."
To hear more about her discussion, watch the interview above with Marche above.
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
GLP-1 Tiering Agreement Reached, Says Optum Rx President
May 3rd 2024Health plans that use Optum Rx as their pharmacy benefit manager (PBM) will be allowed to tier their coverage of GLP-1s and still receive rebates under an agreement the PBM has reached with the manufacturers, says the PBM president. Optum officials said later that the negotiations were still ongoing,
Read More
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
